Treatment of Cellulitis
First-Line Antibiotic Therapy
Beta-lactam monotherapy is the standard of care for typical uncomplicated cellulitis, with a 96% success rate, and MRSA coverage is NOT routinely necessary. 1
Recommended Oral Agents
- Cephalexin 500 mg orally every 6 hours (four times daily) for 5 days is the preferred first-line agent for typical nonpurulent cellulitis 1, 2
- Dicloxacillin 250-500 mg every 6 hours provides excellent streptococcal and MSSA coverage 1, 3
- Amoxicillin, amoxicillin-clavulanate, or penicillin are equally appropriate alternatives 1
- Clindamycin 300-450 mg orally every 6 hours covers both streptococci and MRSA if local resistance is <10% 1
Recommended IV Agents for Hospitalized Patients
- Cefazolin 1-2 g IV every 8 hours is the preferred IV beta-lactam for hospitalized patients requiring parenteral therapy 1
- Nafcillin 2 g IV every 6 hours or oxacillin 2 g IV every 6 hours are alternatives 1
Treatment Duration
Treat for exactly 5 days if clinical improvement has occurred; extend only if symptoms have not improved within this timeframe. 1, 4
- Five-day courses are as effective as 10-day courses for uncomplicated cellulitis based on high-quality randomized controlled trial evidence 1, 4
- Clinical resolution at 14 days with no relapse by 28 days occurred in 98% of patients receiving 5 days versus 98% receiving 10 days 4
- Traditional 7-14 day courses are no longer necessary for uncomplicated cases 1
Common pitfall: Do not reflexively extend treatment to 7-10 days based on residual erythema alone, as some inflammation persists even after bacterial eradication 1
When to Add MRSA Coverage
Add MRSA-active antibiotics ONLY when specific risk factors are present: 1
- Penetrating trauma or injection drug use 1
- Purulent drainage or exudate 1
- Evidence of MRSA infection elsewhere or known nasal MRSA colonization 1
- Systemic inflammatory response syndrome (SIRS): fever >38°C, tachycardia >90 bpm, hypotension, or altered mental status 1
- Failure to respond to beta-lactam therapy after 48-72 hours 1
MRSA Coverage Options
When MRSA coverage is indicated:
- Clindamycin 300-450 mg orally every 6 hours provides single-agent coverage for both streptococci and MRSA (use only if local resistance <10%) 1
- Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily PLUS a beta-lactam (cephalexin, amoxicillin, or penicillin) 1
- Doxycycline 100 mg orally twice daily PLUS a beta-lactam 1
Critical caveat: Never use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for typical cellulitis, as their activity against beta-hemolytic streptococci is unreliable 1
Severe Cellulitis Requiring Hospitalization
Indications for Hospitalization
Admit patients with any of the following: 1
- SIRS criteria (fever, tachycardia, hypotension, altered mental status) 1
- Severe immunocompromise or neutropenia 1
- Concern for deeper or necrotizing infection 1
- Failure of outpatient treatment after 24-48 hours 1
IV Antibiotic Regimens for Severe Infections
For patients with signs of systemic toxicity, rapid progression, or suspected necrotizing fasciitis, mandatory broad-spectrum combination therapy is required: 1
- Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 1
- Alternative: Linezolid 600 mg IV twice daily PLUS piperacillin-tazobactam 1
- Alternative: Vancomycin PLUS a carbapenem (meropenem 1 g IV every 8 hours) 1
- Alternative: Vancomycin PLUS ceftriaxone 2 g IV daily and metronidazole 500 mg IV every 8 hours 1
Treatment duration for severe cellulitis is 7-10 days, not the standard 5 days, with reassessment at 5 days. 1
Transition to Oral Therapy
- Patients can transition to oral antibiotics once clinical improvement is demonstrated, typically after a minimum of 4 days of IV treatment 1
- Oral options include cephalexin, dicloxacillin, or clindamycin 1
Essential Adjunctive Measures
Elevation of the affected extremity is critical and often neglected—it hastens improvement by promoting gravity drainage of edema and inflammatory substances. 1
- Elevate the limb above heart level for at least 30 minutes three times daily 1
- Examine interdigital toe spaces carefully for tinea pedis, fissuring, scaling, or maceration 1
- Treat predisposing conditions including venous insufficiency, lymphedema, eczema, chronic edema, and obesity 1
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults, though evidence is limited 1
Critical caveat: Avoid systemic corticosteroids in diabetic patients despite potential benefit in non-diabetics 1
Special Populations
Diabetic Foot Cellulitis
Diabetic patients with foot cellulitis require broader coverage and longer duration: 1
- Mild infections: dicloxacillin, clindamycin, cephalexin, trimethoprim-sulfamethoxazole, amoxicillin-clavulanate, or levofloxacin 1
- Moderate infections: amoxicillin-clavulanate, levofloxacin, ceftriaxone, ampicillin-sulbactam, or ertapenem 1
- Severe infections: piperacillin-tazobactam, imipenem-cilastatin, or vancomycin plus ceftazidime with or without metronidazole 1
- Median treatment duration extends beyond the standard 5-day course 1
Penicillin/Cephalosporin Allergy
- Clindamycin 300-450 mg orally every 6 hours is the optimal choice for patients allergic to both penicillins and cephalosporins 1
- Provides single-agent coverage for both streptococci and MRSA without requiring combination therapy 1
- Use only if local MRSA clindamycin resistance rates are <10% 1
Pediatric Cellulitis
- Cephalexin 25 mg/kg/day in four divided doses for typical nonpurulent cellulitis 1
- For hospitalized children: vancomycin 15 mg/kg IV every 6 hours as first-line therapy 1
- Alternative: clindamycin 10-13 mg/kg/dose IV every 6-8 hours if stable, no bacteremia, and local resistance <10% 1
- Never use doxycycline in children under 8 years of age due to tooth discoloration and bone growth effects 1
Prevention of Recurrent Cellulitis
Annual recurrence rates are 8-20% in patients with previous leg cellulitis. 1
- Treat tinea pedis and interdigital toe web abnormalities 1
- Manage venous insufficiency with compression stockings once acute infection resolves 1
- Reduce lymphedema 1
- Keep skin well hydrated with emollients 1
For patients with 3-4 episodes per year despite treating predisposing factors, consider prophylactic antibiotics: 1
- Oral penicillin V 250 mg twice daily for 4-52 weeks 1
- Oral erythromycin 250 mg twice daily 1
- Intramuscular benzathine penicillin every 2-4 weeks 1
Monitoring and Treatment Failure
- Reassess within 24-48 hours for outpatients to ensure clinical improvement 1
- If no improvement with appropriate first-line antibiotics, consider resistant organisms (especially MRSA), cellulitis mimickers (DVT, necrotizing fasciitis), or underlying complications 1, 5
- Blood cultures are positive in only 5% of cases and are unnecessary for typical cellulitis 1
- Obtain blood cultures only in patients with severe systemic features, malignancy, neutropenia, or unusual predisposing factors 1
Warning signs requiring immediate surgical consultation: 1